Loading…

Fas-resistance in ATL cell lines not associated with HTLV-I or FAP-1 production

A preventive role for human T-cell leukemia virus type-I (HTLV-I) and Fas-associated phosphatase-1 (FAP-1) in Fas-mediated apoptosis has been reported in HTLV-I-infected cells. In the present study, we examined whether these molecules increased during the acquisition of Fas-resistance in adult T-cel...

Full description

Saved in:
Bibliographic Details
Published in:Cancer letters 1999-12, Vol.147 (1), p.215-219
Main Authors: Yamada, Yasuaki, Sugahara, Kazuyuki, Tsuruda, Kazuto, Nohda, Kazuo, Hata, Tomoko, Maeda, Takahiro, Honda, Miyuki, Tawara, Masayuki, Hayashibara, Toshihisa, Joh, Tatsuroh, Tomonaga, Masao, Miyazaki, Yoshitsugu, Kamihira, Shimeru
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c421t-f7e9418b54f4f15516e4449e5cf7e50aae847bff164d6ca257ee520e04cb1bbf3
cites cdi_FETCH-LOGICAL-c421t-f7e9418b54f4f15516e4449e5cf7e50aae847bff164d6ca257ee520e04cb1bbf3
container_end_page 219
container_issue 1
container_start_page 215
container_title Cancer letters
container_volume 147
creator Yamada, Yasuaki
Sugahara, Kazuyuki
Tsuruda, Kazuto
Nohda, Kazuo
Hata, Tomoko
Maeda, Takahiro
Honda, Miyuki
Tawara, Masayuki
Hayashibara, Toshihisa
Joh, Tatsuroh
Tomonaga, Masao
Miyazaki, Yoshitsugu
Kamihira, Shimeru
description A preventive role for human T-cell leukemia virus type-I (HTLV-I) and Fas-associated phosphatase-1 (FAP-1) in Fas-mediated apoptosis has been reported in HTLV-I-infected cells. In the present study, we examined whether these molecules increased during the acquisition of Fas-resistance in adult T-cell leukemia (ATL) cell lines. SO4, ST1 and KK1 are Fas-sensitive ATL cell lines, and produce small amounts of HTLV-I in vitro. Although their subclones RSO4 and RST1 are completely Fas-resistant, they produced an equivalent amount of HTLV-I to SO4 and ST1. Moreover, FAP-1 mRNA was not detected in these cell lines irrespective of Fas sensitivity. Thus, Fas resistance in ATL cells was not directly associated with the increased production of HTLV-I or FAP-1.
doi_str_mv 10.1016/S0304-3835(99)00313-4
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69426468</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0304383599003134</els_id><sourcerecordid>69426468</sourcerecordid><originalsourceid>FETCH-LOGICAL-c421t-f7e9418b54f4f15516e4449e5cf7e50aae847bff164d6ca257ee520e04cb1bbf3</originalsourceid><addsrcrecordid>eNqFkcFu1DAQhq0KRLeFRyjyAaH2YBgnYyc-oVXVbSutVCQWrpbjjIWrbNLaWSrenmyzAm49zWG-mfn1DWNnEj5JkPrzNygBRVmX6tyYC4BSlgKP2ELWVSEqU8MrtviLHLOTnO8BQGGl3rBjCVqDBLNgdyuXRaIc8-h6Tzz2fLlZc09dx7vYU-b9MHKX8-CjG6nlT3H8yW826x_ilg-Jr5ZfheQPaWh3foxD_5a9Dq7L9O5QT9n31dXm8kas765vL5dr4bGQowgVGZR1ozBgkEpJTYhoSPmpo8A5qrFqQpAaW-1doSoiVQAB-kY2TShP2cd573T6cUd5tNuY96ldT8MuW22w0KjrF0FZodaFhAlUM-jTkHOiYB9S3Lr020qwe-X2Wbnd-7TG2GflFqe594cDu2ZL7X9Ts-MJ-HAAXPauC2kSHfM_riiqOeiXGaNJ269IyWYfafpJGxP50bZDfCHJHw-cm0E</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17466210</pqid></control><display><type>article</type><title>Fas-resistance in ATL cell lines not associated with HTLV-I or FAP-1 production</title><source>Elsevier</source><creator>Yamada, Yasuaki ; Sugahara, Kazuyuki ; Tsuruda, Kazuto ; Nohda, Kazuo ; Hata, Tomoko ; Maeda, Takahiro ; Honda, Miyuki ; Tawara, Masayuki ; Hayashibara, Toshihisa ; Joh, Tatsuroh ; Tomonaga, Masao ; Miyazaki, Yoshitsugu ; Kamihira, Shimeru</creator><creatorcontrib>Yamada, Yasuaki ; Sugahara, Kazuyuki ; Tsuruda, Kazuto ; Nohda, Kazuo ; Hata, Tomoko ; Maeda, Takahiro ; Honda, Miyuki ; Tawara, Masayuki ; Hayashibara, Toshihisa ; Joh, Tatsuroh ; Tomonaga, Masao ; Miyazaki, Yoshitsugu ; Kamihira, Shimeru</creatorcontrib><description>A preventive role for human T-cell leukemia virus type-I (HTLV-I) and Fas-associated phosphatase-1 (FAP-1) in Fas-mediated apoptosis has been reported in HTLV-I-infected cells. In the present study, we examined whether these molecules increased during the acquisition of Fas-resistance in adult T-cell leukemia (ATL) cell lines. SO4, ST1 and KK1 are Fas-sensitive ATL cell lines, and produce small amounts of HTLV-I in vitro. Although their subclones RSO4 and RST1 are completely Fas-resistant, they produced an equivalent amount of HTLV-I to SO4 and ST1. Moreover, FAP-1 mRNA was not detected in these cell lines irrespective of Fas sensitivity. Thus, Fas resistance in ATL cells was not directly associated with the increased production of HTLV-I or FAP-1.</description><identifier>ISSN: 0304-3835</identifier><identifier>EISSN: 1872-7980</identifier><identifier>DOI: 10.1016/S0304-3835(99)00313-4</identifier><identifier>PMID: 10660109</identifier><identifier>CODEN: CALEDQ</identifier><language>eng</language><publisher>Shannon: Elsevier Ireland Ltd</publisher><subject>Adult T-cell leukemia ; AIDS/HIV ; Antibodies, Monoclonal - pharmacology ; Apoptosis ; Apoptosis - drug effects ; Apoptosis - immunology ; Biological and medical sciences ; Blotting, Southern ; Carrier Proteins - biosynthesis ; Carrier Proteins - genetics ; Carrier Proteins - immunology ; Clone Cells ; DNA Fragmentation - drug effects ; DNA, Complementary - biosynthesis ; Drug Resistance, Neoplasm ; Fas ; Fas antigen ; fas Receptor - immunology ; fas Receptor - pharmacology ; Fas-associated phosphatase-1 ; Hematologic and hematopoietic diseases ; Human T-cell leukemia virus type-I ; human T-lymphotropic virus 1 ; Human T-lymphotropic virus 1 - genetics ; Human T-lymphotropic virus 1 - isolation &amp; purification ; Humans ; Leukemia, T-Cell - genetics ; Leukemia, T-Cell - metabolism ; Leukemia, T-Cell - pathology ; Leukemia, T-Cell - virology ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Medical sciences ; Protein Phosphatase 1 ; Protein Tyrosine Phosphatase, Non-Receptor Type 13 ; Protein Tyrosine Phosphatases - biosynthesis ; Protein Tyrosine Phosphatases - genetics ; Protein Tyrosine Phosphatases - immunology ; Proto-Oncogene Proteins c-bcl-2 - biosynthesis ; Reverse Transcriptase Polymerase Chain Reaction ; RNA, Messenger - biosynthesis ; Tumor Cells, Cultured ; Virus Integration - genetics</subject><ispartof>Cancer letters, 1999-12, Vol.147 (1), p.215-219</ispartof><rights>1999 Elsevier Science Ireland Ltd</rights><rights>2000 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c421t-f7e9418b54f4f15516e4449e5cf7e50aae847bff164d6ca257ee520e04cb1bbf3</citedby><cites>FETCH-LOGICAL-c421t-f7e9418b54f4f15516e4449e5cf7e50aae847bff164d6ca257ee520e04cb1bbf3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1227468$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10660109$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yamada, Yasuaki</creatorcontrib><creatorcontrib>Sugahara, Kazuyuki</creatorcontrib><creatorcontrib>Tsuruda, Kazuto</creatorcontrib><creatorcontrib>Nohda, Kazuo</creatorcontrib><creatorcontrib>Hata, Tomoko</creatorcontrib><creatorcontrib>Maeda, Takahiro</creatorcontrib><creatorcontrib>Honda, Miyuki</creatorcontrib><creatorcontrib>Tawara, Masayuki</creatorcontrib><creatorcontrib>Hayashibara, Toshihisa</creatorcontrib><creatorcontrib>Joh, Tatsuroh</creatorcontrib><creatorcontrib>Tomonaga, Masao</creatorcontrib><creatorcontrib>Miyazaki, Yoshitsugu</creatorcontrib><creatorcontrib>Kamihira, Shimeru</creatorcontrib><title>Fas-resistance in ATL cell lines not associated with HTLV-I or FAP-1 production</title><title>Cancer letters</title><addtitle>Cancer Lett</addtitle><description>A preventive role for human T-cell leukemia virus type-I (HTLV-I) and Fas-associated phosphatase-1 (FAP-1) in Fas-mediated apoptosis has been reported in HTLV-I-infected cells. In the present study, we examined whether these molecules increased during the acquisition of Fas-resistance in adult T-cell leukemia (ATL) cell lines. SO4, ST1 and KK1 are Fas-sensitive ATL cell lines, and produce small amounts of HTLV-I in vitro. Although their subclones RSO4 and RST1 are completely Fas-resistant, they produced an equivalent amount of HTLV-I to SO4 and ST1. Moreover, FAP-1 mRNA was not detected in these cell lines irrespective of Fas sensitivity. Thus, Fas resistance in ATL cells was not directly associated with the increased production of HTLV-I or FAP-1.</description><subject>Adult T-cell leukemia</subject><subject>AIDS/HIV</subject><subject>Antibodies, Monoclonal - pharmacology</subject><subject>Apoptosis</subject><subject>Apoptosis - drug effects</subject><subject>Apoptosis - immunology</subject><subject>Biological and medical sciences</subject><subject>Blotting, Southern</subject><subject>Carrier Proteins - biosynthesis</subject><subject>Carrier Proteins - genetics</subject><subject>Carrier Proteins - immunology</subject><subject>Clone Cells</subject><subject>DNA Fragmentation - drug effects</subject><subject>DNA, Complementary - biosynthesis</subject><subject>Drug Resistance, Neoplasm</subject><subject>Fas</subject><subject>Fas antigen</subject><subject>fas Receptor - immunology</subject><subject>fas Receptor - pharmacology</subject><subject>Fas-associated phosphatase-1</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Human T-cell leukemia virus type-I</subject><subject>human T-lymphotropic virus 1</subject><subject>Human T-lymphotropic virus 1 - genetics</subject><subject>Human T-lymphotropic virus 1 - isolation &amp; purification</subject><subject>Humans</subject><subject>Leukemia, T-Cell - genetics</subject><subject>Leukemia, T-Cell - metabolism</subject><subject>Leukemia, T-Cell - pathology</subject><subject>Leukemia, T-Cell - virology</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Medical sciences</subject><subject>Protein Phosphatase 1</subject><subject>Protein Tyrosine Phosphatase, Non-Receptor Type 13</subject><subject>Protein Tyrosine Phosphatases - biosynthesis</subject><subject>Protein Tyrosine Phosphatases - genetics</subject><subject>Protein Tyrosine Phosphatases - immunology</subject><subject>Proto-Oncogene Proteins c-bcl-2 - biosynthesis</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>RNA, Messenger - biosynthesis</subject><subject>Tumor Cells, Cultured</subject><subject>Virus Integration - genetics</subject><issn>0304-3835</issn><issn>1872-7980</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNqFkcFu1DAQhq0KRLeFRyjyAaH2YBgnYyc-oVXVbSutVCQWrpbjjIWrbNLaWSrenmyzAm49zWG-mfn1DWNnEj5JkPrzNygBRVmX6tyYC4BSlgKP2ELWVSEqU8MrtviLHLOTnO8BQGGl3rBjCVqDBLNgdyuXRaIc8-h6Tzz2fLlZc09dx7vYU-b9MHKX8-CjG6nlT3H8yW826x_ilg-Jr5ZfheQPaWh3foxD_5a9Dq7L9O5QT9n31dXm8kas765vL5dr4bGQowgVGZR1ozBgkEpJTYhoSPmpo8A5qrFqQpAaW-1doSoiVQAB-kY2TShP2cd573T6cUd5tNuY96ldT8MuW22w0KjrF0FZodaFhAlUM-jTkHOiYB9S3Lr020qwe-X2Wbnd-7TG2GflFqe594cDu2ZL7X9Ts-MJ-HAAXPauC2kSHfM_riiqOeiXGaNJ269IyWYfafpJGxP50bZDfCHJHw-cm0E</recordid><startdate>19991201</startdate><enddate>19991201</enddate><creator>Yamada, Yasuaki</creator><creator>Sugahara, Kazuyuki</creator><creator>Tsuruda, Kazuto</creator><creator>Nohda, Kazuo</creator><creator>Hata, Tomoko</creator><creator>Maeda, Takahiro</creator><creator>Honda, Miyuki</creator><creator>Tawara, Masayuki</creator><creator>Hayashibara, Toshihisa</creator><creator>Joh, Tatsuroh</creator><creator>Tomonaga, Masao</creator><creator>Miyazaki, Yoshitsugu</creator><creator>Kamihira, Shimeru</creator><general>Elsevier Ireland Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>19991201</creationdate><title>Fas-resistance in ATL cell lines not associated with HTLV-I or FAP-1 production</title><author>Yamada, Yasuaki ; Sugahara, Kazuyuki ; Tsuruda, Kazuto ; Nohda, Kazuo ; Hata, Tomoko ; Maeda, Takahiro ; Honda, Miyuki ; Tawara, Masayuki ; Hayashibara, Toshihisa ; Joh, Tatsuroh ; Tomonaga, Masao ; Miyazaki, Yoshitsugu ; Kamihira, Shimeru</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c421t-f7e9418b54f4f15516e4449e5cf7e50aae847bff164d6ca257ee520e04cb1bbf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Adult T-cell leukemia</topic><topic>AIDS/HIV</topic><topic>Antibodies, Monoclonal - pharmacology</topic><topic>Apoptosis</topic><topic>Apoptosis - drug effects</topic><topic>Apoptosis - immunology</topic><topic>Biological and medical sciences</topic><topic>Blotting, Southern</topic><topic>Carrier Proteins - biosynthesis</topic><topic>Carrier Proteins - genetics</topic><topic>Carrier Proteins - immunology</topic><topic>Clone Cells</topic><topic>DNA Fragmentation - drug effects</topic><topic>DNA, Complementary - biosynthesis</topic><topic>Drug Resistance, Neoplasm</topic><topic>Fas</topic><topic>Fas antigen</topic><topic>fas Receptor - immunology</topic><topic>fas Receptor - pharmacology</topic><topic>Fas-associated phosphatase-1</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Human T-cell leukemia virus type-I</topic><topic>human T-lymphotropic virus 1</topic><topic>Human T-lymphotropic virus 1 - genetics</topic><topic>Human T-lymphotropic virus 1 - isolation &amp; purification</topic><topic>Humans</topic><topic>Leukemia, T-Cell - genetics</topic><topic>Leukemia, T-Cell - metabolism</topic><topic>Leukemia, T-Cell - pathology</topic><topic>Leukemia, T-Cell - virology</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Medical sciences</topic><topic>Protein Phosphatase 1</topic><topic>Protein Tyrosine Phosphatase, Non-Receptor Type 13</topic><topic>Protein Tyrosine Phosphatases - biosynthesis</topic><topic>Protein Tyrosine Phosphatases - genetics</topic><topic>Protein Tyrosine Phosphatases - immunology</topic><topic>Proto-Oncogene Proteins c-bcl-2 - biosynthesis</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>RNA, Messenger - biosynthesis</topic><topic>Tumor Cells, Cultured</topic><topic>Virus Integration - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yamada, Yasuaki</creatorcontrib><creatorcontrib>Sugahara, Kazuyuki</creatorcontrib><creatorcontrib>Tsuruda, Kazuto</creatorcontrib><creatorcontrib>Nohda, Kazuo</creatorcontrib><creatorcontrib>Hata, Tomoko</creatorcontrib><creatorcontrib>Maeda, Takahiro</creatorcontrib><creatorcontrib>Honda, Miyuki</creatorcontrib><creatorcontrib>Tawara, Masayuki</creatorcontrib><creatorcontrib>Hayashibara, Toshihisa</creatorcontrib><creatorcontrib>Joh, Tatsuroh</creatorcontrib><creatorcontrib>Tomonaga, Masao</creatorcontrib><creatorcontrib>Miyazaki, Yoshitsugu</creatorcontrib><creatorcontrib>Kamihira, Shimeru</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamada, Yasuaki</au><au>Sugahara, Kazuyuki</au><au>Tsuruda, Kazuto</au><au>Nohda, Kazuo</au><au>Hata, Tomoko</au><au>Maeda, Takahiro</au><au>Honda, Miyuki</au><au>Tawara, Masayuki</au><au>Hayashibara, Toshihisa</au><au>Joh, Tatsuroh</au><au>Tomonaga, Masao</au><au>Miyazaki, Yoshitsugu</au><au>Kamihira, Shimeru</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fas-resistance in ATL cell lines not associated with HTLV-I or FAP-1 production</atitle><jtitle>Cancer letters</jtitle><addtitle>Cancer Lett</addtitle><date>1999-12-01</date><risdate>1999</risdate><volume>147</volume><issue>1</issue><spage>215</spage><epage>219</epage><pages>215-219</pages><issn>0304-3835</issn><eissn>1872-7980</eissn><coden>CALEDQ</coden><abstract>A preventive role for human T-cell leukemia virus type-I (HTLV-I) and Fas-associated phosphatase-1 (FAP-1) in Fas-mediated apoptosis has been reported in HTLV-I-infected cells. In the present study, we examined whether these molecules increased during the acquisition of Fas-resistance in adult T-cell leukemia (ATL) cell lines. SO4, ST1 and KK1 are Fas-sensitive ATL cell lines, and produce small amounts of HTLV-I in vitro. Although their subclones RSO4 and RST1 are completely Fas-resistant, they produced an equivalent amount of HTLV-I to SO4 and ST1. Moreover, FAP-1 mRNA was not detected in these cell lines irrespective of Fas sensitivity. Thus, Fas resistance in ATL cells was not directly associated with the increased production of HTLV-I or FAP-1.</abstract><cop>Shannon</cop><pub>Elsevier Ireland Ltd</pub><pmid>10660109</pmid><doi>10.1016/S0304-3835(99)00313-4</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0304-3835
ispartof Cancer letters, 1999-12, Vol.147 (1), p.215-219
issn 0304-3835
1872-7980
language eng
recordid cdi_proquest_miscellaneous_69426468
source Elsevier
subjects Adult T-cell leukemia
AIDS/HIV
Antibodies, Monoclonal - pharmacology
Apoptosis
Apoptosis - drug effects
Apoptosis - immunology
Biological and medical sciences
Blotting, Southern
Carrier Proteins - biosynthesis
Carrier Proteins - genetics
Carrier Proteins - immunology
Clone Cells
DNA Fragmentation - drug effects
DNA, Complementary - biosynthesis
Drug Resistance, Neoplasm
Fas
Fas antigen
fas Receptor - immunology
fas Receptor - pharmacology
Fas-associated phosphatase-1
Hematologic and hematopoietic diseases
Human T-cell leukemia virus type-I
human T-lymphotropic virus 1
Human T-lymphotropic virus 1 - genetics
Human T-lymphotropic virus 1 - isolation & purification
Humans
Leukemia, T-Cell - genetics
Leukemia, T-Cell - metabolism
Leukemia, T-Cell - pathology
Leukemia, T-Cell - virology
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Medical sciences
Protein Phosphatase 1
Protein Tyrosine Phosphatase, Non-Receptor Type 13
Protein Tyrosine Phosphatases - biosynthesis
Protein Tyrosine Phosphatases - genetics
Protein Tyrosine Phosphatases - immunology
Proto-Oncogene Proteins c-bcl-2 - biosynthesis
Reverse Transcriptase Polymerase Chain Reaction
RNA, Messenger - biosynthesis
Tumor Cells, Cultured
Virus Integration - genetics
title Fas-resistance in ATL cell lines not associated with HTLV-I or FAP-1 production
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T14%3A02%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fas-resistance%20in%20ATL%20cell%20lines%20not%20associated%20with%20HTLV-I%20or%20FAP-1%20production&rft.jtitle=Cancer%20letters&rft.au=Yamada,%20Yasuaki&rft.date=1999-12-01&rft.volume=147&rft.issue=1&rft.spage=215&rft.epage=219&rft.pages=215-219&rft.issn=0304-3835&rft.eissn=1872-7980&rft.coden=CALEDQ&rft_id=info:doi/10.1016/S0304-3835(99)00313-4&rft_dat=%3Cproquest_cross%3E69426468%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c421t-f7e9418b54f4f15516e4449e5cf7e50aae847bff164d6ca257ee520e04cb1bbf3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17466210&rft_id=info:pmid/10660109&rfr_iscdi=true